These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14357977)

  • 1. Studies on the plasma defect in hemophilia.
    JOHNSON SA; SEEGERS WH
    Rev Hematol; 1954; 9(3 bis):529-35. PubMed ID: 14357977
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; the effect in vitro and in vivo on the coagulation time in hemophilia of a prothrombin and fibrinogen-free normal plasma and its derived protein fractions.
    LEWIS JH; SOULIER JP; TAYLOR FH
    J Clin Invest; 1946 Nov; 25(6):876-9. PubMed ID: 20282730
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemophilia with a normal blood coagulation time. So-called attenuated atypical hemophilia].
    Fiehrer A
    Bull Acad Natl Med; 1971 Jan 5-12; 155(1):27-30. PubMed ID: 4932854
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; an in vitro and in vivo comparison of normal and hemophilic whole blood, plasma and derived plasma protein fractions.
    LEWIS JH; DAVIDSON CS
    J Clin Invest; 1946 Nov; 25(6):870-5. PubMed ID: 20282729
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihemophilic globulin assay following plasma infusions in hemophilia.
    DOUGLAS AS
    J Lab Clin Med; 1958 Jun; 51(6):850-9. PubMed ID: 13549826
    [No Abstract]   [Full Text] [Related]  

  • 7. [On certain peculiarities of the blood coagulation system in hemophilia].
    Rutberg RA
    Probl Gematol Pereliv Krovi; 1966 Nov; 11(11):9-15. PubMed ID: 6001927
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemophilic syndrome: effect of lyophilized plasma and effect of serum fractions on coagulation in vitro].
    MARCACCI M
    Prog Med (Napoli); 1954 Jan; 10(2):47-53. PubMed ID: 13155632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Research on the antithromboplastin factors in hemophilia. 1. The plasma antithromboplastin of Tocantins].
    CHEVALLIER P; FIEHRER A; BILSKI-PASQUIER G; SAMAMA M
    Sang; 1955; 26(4):362-76. PubMed ID: 13246570
    [No Abstract]   [Full Text] [Related]  

  • 10. A theoretical consideration of the blood clotting mechanisms in hemophilia.
    SEEGERS WH
    Schweiz Med Wochenschr; 1954 Jul; 84(29):781-3. PubMed ID: 13195621
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of hemophilia; the assay of the antihemophilic clot-promoting principle in normal human plasma with some observations on the relative potency of certain plasma fractions.
    ALEXANDER B; LANDWEHR G
    J Clin Invest; 1948 Jan; 27(1):98-105. PubMed ID: 18897631
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correction in vitro of A and B hemophilia by various dilutions of normal blood: modifications of clotting time and of prothrombin consumption].
    SOULIER JP; LARRIEU MJ
    Sem Hop; 1954 Aug 26-30; 30(52-53):3033-42. PubMed ID: 13195756
    [No Abstract]   [Full Text] [Related]  

  • 13. Is hemophilia a disease of the tissue factor pathway of coagulation?
    Nemerson Y; Zur M
    Prog Clin Biol Res; 1981; 72():77-83. PubMed ID: 6801686
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-hemophilic globulin levels in carriers of hemophilia A.
    RAPAPORT SI; PATCH MJ; MOORE FJ
    J Clin Invest; 1960 Nov; 39(11):1619-25. PubMed ID: 13739554
    [No Abstract]   [Full Text] [Related]  

  • 15. [Autocorrection of coagulation time in Hemophilia A].
    Schneer JH; Chipail A; Mănăila T
    Rev Med Chir Soc Med Nat Iasi; 1975; 79(2):211-4. PubMed ID: 1166156
    [No Abstract]   [Full Text] [Related]  

  • 16. An historical review: the development of laboratory techniques in the study of hemophilia.
    GRACE MG
    Can J Med Technol; 1960 Dec; 22():111-8. PubMed ID: 13707629
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on a circulating anticoagulant against antihemophilic factor in patients with hemophilia A].
    van Creveld S; Mochtar IA; Charante-Meulen CC
    Ned Tijdschr Geneeskd; 1967 Sep; 111(37):1589-93. PubMed ID: 5602751
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood coagulation studies of various hematological disorders.
    Shimada A
    Nagoya J Med Sci; 1966 Dec; 29(2):119-28. PubMed ID: 5984524
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coagulography and certain indicators of the blood coagulation system in hemopphilia A].
    Tarasova LN; Koniukhov SG
    Lab Delo; 1976; (1):52-3. PubMed ID: 56495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical characteristics of hemophilia in children with circulatory anticoagulants in the blood].
    Iakunina LN; Plakhuta TG
    Vopr Okhr Materin Det; 1977 Jul; 22(7):47-51. PubMed ID: 906379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.